Local and Systemic Immune Dysregulation Alters Glioma Growth in Hyperglycemic Mice
Ian Y. Zhang(Beijing Tongren Hospital), Behnam Badie(City Of Hope National Medical Center), Darya Alizadeh(City Of Hope National Medical Center), Raju Pillai(City Of Hope National Medical Center), Hang Gao(Zhejiang Chinese Medical University), Yanyan Song(Second Affiliated Hospital of Jilin University), Huili Liu(Huanghe Science and Technology College), Leying Zhang(City Of Hope National Medical Center), Shunan Liu(Jilin University), Hui Zhou(Zhejiang A & F University), Hongwei Yin(Agricultural Genomics Institute at Shenzhen)
Cited by 16
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754
A compendium of genetic regulatory effects across pig tissues
|Nature Genetics|2022|255
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
|Frontiers in Immunology|2017|216